US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Corgi Genomics & Precision Medicine ETF

36.11

-0.2930-0.80%

Post-market: 35.53-0.5770-1.60%16:10 EDT

Volume:2K

Turnover:73.49K

Market Cap:1.26M

PE:- -

High:36.11

Open:36.01

Low:35.50

Close:36.40

52wk High:39.65

52wk Low:23.88

Shares:35.00K

Float Shares:35.00K

Volume Ratio:0.18

T/O Rate:5.89%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Vertex to Raise Up to C$7 Million in Subordinated Loan with Attached Warrants

Press Release: Vertex Resource GROUP LTD. Announces Subordinated TERM LOAN of up to C$7,000,000

Illumina to Announce Third Quarter 2026 Financial Results

Guardant announces Europe approval of Guardnat360 CDx as Etcamaha companion

Guardant Health Wins EU CE Mark for Guardant360 CDx as Camizestrant Companion Diagnostic in ER-Positive Breast Cancer

Guardant Health Announces Approval in Europe of Guardant360® Cdx as Companion Diagnostic for AstraZeneca’s Etcamah™ (Camizestrant) in Advanced Er-Positive Breast Cancer

THOMSON REUTERS

Illumina to Release Q3 2026 Results, Host Conference Call

Guardant Health to Report Q3 2026 Financial Results After Market Close, Host Conference Call

Illumina Launches New Genomic AI Model for Rare Disease Research

MT Newswires Live

Thermo Fisher Scientific Inc Stock (TMO) Opened Down by 3.42% on Oct 8: What Investors Need To Know

Illumina Releases SpliceAI2, Says Model Identifies 17% More Disease-Relevant Splice Variants in Rare Disease Dataset

Illumina Releases Spliceai2 to Help Advance Rare Disease Research

THOMSON REUTERS

All Invest Securities Reaffirms Buy Rating on ABL Texcell Diagnostics as Texcell Integration Boosts Growth Outlook

Alnylam Pharmaceuticals (ALNY) Is Under Securities Fraud Investigation

Simply Wall St.

Vertex to Report Q3 2026 Financial Results, Host Conference Call and Webcast

Novartis announces FDA approval of Rhapsido for symptomatic dermographism

Novartis Rhapsido® (remibrutinib) receives FDA approval as first treatment for symptomatic dermographism (SD), expanding its use beyond chronic spontaneous urticaria (CSU)

Guardant Health is Maintained at Overweight by Barclays

Thermo Fisher price target raised to $750 from $650 at Barclays

Guardant Health Inc Stock (GH) Moved Down by 8.27% on Oct 6: What Investors Need To Know

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au.etasphere.com/stock/GNMX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"GNMX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNMX\",,,,,undefined,":{"symbol":"GNMX","market":"US","secType":"STK","nameCN":"Corgi Genomics & Precision Medicine ETF","latestPrice":36.107,"timestamp":1791489600000,"preClose":36.4,"halted":0,"volume":2061,"hourTrading":{"tag":"盘后","latestPrice":35.53,"preClose":36.107,"latestTime":"16:10 EDT","volume":6,"amount":216.642,"timestamp":1791490204181,"change":-0.577,"changeRate":-0.01598,"amplitude":0},"delay":0,"changeRate":-0.00804945054945053,"floatShares":35000,"shares":35000,"eps":0,"marketStatus":"Closed","change":-0.293,"latestTime":"10-08 16:00:00 EDT","open":36.01,"high":36.107,"low":35.5,"amount":73486,"amplitude":0.016676,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791532800000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":1302235200000,"exchange":"CBOE","adjPreClose":36.4,"nav":36.43,"aum":1275050,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":35.53,"preClose":36.107,"latestTime":"16:10 EDT","volume":6,"amount":216.642,"timestamp":1791490204181,"change":-0.577,"changeRate":-0.01598,"amplitude":0},"volumeRatio":0.17876,"impliedVol":0.0861,"impliedVolPercentile":0.2626},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNMX\",,,,,undefined,":{"symbol":"GNMX","floatShares":35000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.17876,"shares":35000,"dividePrice":0,"high":36.107,"amplitude":0.016676,"preClose":36.4,"low":35.5,"week52Low":23.88,"pbRate":"--","week52High":39.645,"institutionHeld":0,"latestPrice":36.107,"eps":0,"divideRate":0,"volume":2061,"delay":0,"ttmEps":0,"open":36.01,"prevYearClose":25.56,"prevWeekClose":37.73,"prevMonthClose":38.3481,"prevQuarterClose":38.3481,"fiveDayClose":37.3454,"twentyDayClose":33.901,"sixtyDayClose":31.0031},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GNMX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GNMX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GNMX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GNMX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2674886821","title":"Vertex to Raise Up to C$7 Million in Subordinated Loan with Attached Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2674886821","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674886821?lang=en_us&edition=fundamental","pubTime":"2026-10-09 07:38","pubTimestamp":1791502698,"startTime":"0","endTime":"0","summary":"An update from Vertex Resource Group Ltd. ( ($TSE:VTX) ) is now available. Vertex Resource Group Ltd., a North American environmental services firm...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-to-raise-up-to-c7-million-in-subordinated-loan-with-attached-warrants?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-to-raise-up-to-c7-million-in-subordinated-loan-with-attached-warrants?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1035775433.USD","LU0432979614.USD","BK4585","IE00BJT1NW94.SGD","LU1093756168.USD","SG9999001176.USD","LU1674673428.USD","LU2362541513.USD","IE00B19Z9P08.USD","IE00B19Z3581.USD","LU2362541273.HKD","IBBQ","LU1778281490.HKD","BIB","LU0256863811.USD","LU0757428866.USD","LU1430594728.SGD","TBXU","LU0823416689.USD","LU2417539215.USD","BK4532","VRTX","IDNA","IE00B894F039.SGD","LU2237438978.USD","BBH","BK4567","IE00B19Z3B42.SGD","PBE","IE00B4R5TH58.HKD","LU1815336091.USD","LU0058720904.USD","LU0417517546.SGD","IE00B2B36J28.USD","LU1559883803.SGD","SGXZ57979304.SGD","GNMX","SG9999013999.USD","LU2089984988.USD","BK4588","LU2462157665.USD","LU2456880835.USD","BK4139","IE0009355771.USD","IBB","VERX","IE0002141913.USD","LU0061475181.USD","LU0566484027.USD","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674883067","title":"Press Release: Vertex Resource GROUP LTD. Announces Subordinated TERM LOAN of up to C$7,000,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2674883067","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674883067?lang=en_us&edition=fundamental","pubTime":"2026-10-09 06:30","pubTimestamp":1791498600,"startTime":"0","endTime":"0","summary":"SHERWOOD PARK, AB, Oct. 8, 2026 /CNW/ -- (TSXV: VTX) -- Vertex Resource Group Ltd. (\"Vertex\" or the \"Corporation\") announces its intention to enter into a subordinated credit arrangement with Factory ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0432979614.USD","LU1674673691.USD","LU1674673428.USD","IBBQ","IE00B4R5TH58.HKD","SG9999001176.SGD","91013","BBH","IE00B19Z9Z06.USD","LU2462157665.USD","LU0889565916.HKD","VRTX","LU0061475181.USD","BK4567","LU1093756325.SGD","LU2362540622.SGD","IDNA","IE00BJT1NW94.SGD","LU2237438978.USD","IE0002141913.USD","BK4585","LU0289739699.SGD","BK4533","LU1778281490.HKD","LU2417539215.USD","VERX","PBE","BK4588","LU0079474960.USD","LU2362541273.HKD","SG9999001176.USD","TBXU","91512","IE0009355771.USD","LU0320765992.SGD","LU1585245621.USD","SGXZ57979304.SGD","IE00B894F039.SGD","IE0002270589.USD","GNMX","BIB","IBB","BK4139","LU0757428866.USD","LU2468319806.SGD","SG9999013999.USD","IE00BZ9MQY76.HKD","LU0109394709.USD","LU2456880835.USD","LU0566484027.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674954883","title":"Illumina to Announce Third Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2674954883","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674954883?lang=en_us&edition=fundamental","pubTime":"2026-10-09 05:57","pubTimestamp":1791496677,"startTime":"0","endTime":"0","summary":"BRIEF-Illumina To Announce Third Quarter 2026 Financial ResultsOct 8 (Reuters)-Illumina IncILMN.O:ILLUMINA TO ANNOUNCE THIRD QUARTER 2026 FINANCIAL RESULTS ON THURSDAY, OCTOBER 29, 2026Source text:ID:nPn8zP2xSaFurther company coverage:ILMN.O","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261008:nTUA4SFLGW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","BK4588","BK4121","LU0029874061.USD","BK4585","ILMN","BK4534","BK4548","GNOM","GNMX","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674000684","title":"Guardant announces Europe approval of Guardnat360 CDx as Etcamaha companion","url":"https://stock-news.laohu8.com/highlight/detail?id=2674000684","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674000684?lang=en_us&edition=fundamental","pubTime":"2026-10-09 04:15","pubTimestamp":1791490537,"startTime":"0","endTime":"0","summary":"Guardant Health (GH) announced that Guardant360 CDx has received CE-marking under Europe’s in Vitro Diagnostic Medical Devices Regulation as a comp...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/guardant-announces-europe-approval-of-guardnat360-cdx-as-etcamaha-companion-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/guardant-announces-europe-approval-of-guardnat360-cdx-as-etcamaha-companion-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4585","HELX","LU0889565916.HKD","PTH","LU0320765992.SGD","BK4196","LFSC","EKG","GH","LU0109394709.USD","FFOX","GNOM","BK4535","GDOC","BK4551","GNMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674000800","title":"Guardant Health Wins EU CE Mark for Guardant360 CDx as Camizestrant Companion Diagnostic in ER-Positive Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2674000800","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674000800?lang=en_us&edition=fundamental","pubTime":"2026-10-09 04:12","pubTimestamp":1791490344,"startTime":"0","endTime":"0","summary":"Guardant Health wins EU CE mark for Guardant360 CDx as camizestrant companion diagnostic in ER-positive breast cancerGuardant Health secured EU CE-marking for Guardant360 CDx as a companion diagnostic","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261008:nNDL7WpmQr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","LU0889565916.HKD","LU0109394709.USD","PTH","GDOC","GH","HELX","FFOX","GNMX","BK4588","BK4196","BK4551","GNOM","BK4585","LFSC","EKG","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674802000","title":"Guardant Health Announces Approval in Europe of Guardant360® Cdx as Companion Diagnostic for AstraZeneca’s Etcamah™ (Camizestrant) in Advanced Er-Positive Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2674802000","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674802000?lang=en_us&edition=fundamental","pubTime":"2026-10-09 04:12","pubTimestamp":1791490320,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261008:nTUA8LV3XK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0784385840.USD","LU0345777659.USD","LU2023251221.USD","LU0997586515.USD","LU2237443622.USD","LU0661504455.SGD","LU0345777147.USD","EKG","HELX","AZN.UK","LU0029864427.USD","LU0960981461.USD","LU0011850046.USD","LU0784383803.USD","LU0757432116.USD","FFOX","GDOC","IE00B3T34201.USD","LU1153585028.USD","LU1261432733.SGD","LU2125909247.SGD","GH","GNMX","LU1153584641.USD","LU1323610961.USD","LU0949170426.SGD","LU1496350171.SGD","LU0827474353.SGD","LU1863844749.USD","IE00BJT1NW94.SGD","LU0949170772.SGD","LU0823399737.USD","LU1481599808.USD","LU1267930813.SGD","LFSC","LU1923622614.USD","LU2539964713.USD","LU1015430645.USD","LU1057294990.SGD","LU1989772923.USD","03165","LU0972486137.USD","LU0882574055.USD","LU0058720904.USD","LU2293690249.USD","PTH","GNOM","LU0823416689.USD","LU0211326755.USD","LU0526926950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674600704","title":"Illumina to Release Q3 2026 Results, Host Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2674600704","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674600704?lang=en_us&edition=fundamental","pubTime":"2026-10-09 04:07","pubTimestamp":1791490066,"startTime":"0","endTime":"0","summary":"Illumina to release Q3 2026 results, host conference callIllumina schedules third-quarter 2026 results release for Oct. 29, 2026, following the market close.Conference call set for Oct. 29, 2026 at 1:","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261008:nNDLbLrX8l:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0029874061.USD","BK4535","GNOM","BK4585","LU0128526141.USD","BK4588","ILMN","BK4548","BK4121","GNMX","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674007701","title":"Guardant Health to Report Q3 2026 Financial Results After Market Close, Host Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2674007701","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674007701?lang=en_us&edition=fundamental","pubTime":"2026-10-09 04:05","pubTimestamp":1791489926,"startTime":"0","endTime":"0","summary":"Guardant Health to report Q3 2026 financial results after market close, host conference callGuardant Health schedules third-quarter 2026 results release for Nov. 5, 2026, following the market close.Ma","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261008:nNDLWjfQL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","HELX","LU0320765992.SGD","BK4535","FFOX","GNOM","BK4585","LU0889565916.HKD","BK4588","GH","PTH","LFSC","GDOC","EKG","GNMX","BK4551","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673008720","title":"Illumina Launches New Genomic AI Model for Rare Disease Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2673008720","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673008720?lang=en_us&edition=fundamental","pubTime":"2026-10-08 21:55","pubTimestamp":1791467748,"startTime":"0","endTime":"0","summary":"Illumina  said Thursday it launched new genomic AI model SpliceAI2 to support rare disease research projects.The new model allows researchers to identify disease-relevant splice variants, the company said.When applied to a rare disease research dataset, SpliceAI2 identified 17% more disease-relevant variants compared with other splicing models, Illumina said.SpliceAI2 may be accessed through the BioInsight applications, the company said.Illumina shares were down 3.9% in Thursday trading.Price: 257.30, Change: -10.46, Percent Change: -3.91","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4534","QTOC","ARTY","GNMX","LU0029874061.USD","AIPO","BK4548","AGIX","ILMN","BK4535","CHAT","GNOM","BK4585","BK4588","VTHR","BK4121","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673008207","title":"Thermo Fisher Scientific Inc Stock (TMO) Opened Down by 3.42% on Oct 8: What Investors Need To Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2673008207","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673008207?lang=en_us&edition=fundamental","pubTime":"2026-10-08 21:47","pubTimestamp":1791467236,"startTime":"0","endTime":"0","summary":"• Thermo Fisher stock fell due to profit-taking and broader healthcare sector weakness.\n• Investors adopted cautious postures ahead of upcoming third-quarter financial results.\n• Macroeconomic factors, elevated bond yields, and foreign exchange headwinds weighed on prices.","market":"sh","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262206381-market-movers-tmo-20261008","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0011850046.USD","LU1670628061.USD","LU0251131958.USD","LU0708994859.HKD","LU1923622614.USD","LU1983299246.USD","IE00B1BXHZ80.USD","BK4566","IE00BQXX3D17.EUR","LU1791710400.SGD","LU0029864427.USD","LU0122379950.USD","LU2125909759.SGD","LU2764263203.CNY","FMED","LU0557290698.USD","LU2063271972.USD","HRTS","LU2125909593.SGD","IE00BJT1NW94.SGD","IE00B19Z8W00.USD","GNMX","BK4534","LU1854103824.USD","LU1057294990.SGD","LU0882574055.USD","LU2089984988.USD","LU0957791311.USD","LU1988902786.USD","LU1064131342.USD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","LU1712237335.SGD","LU2125909247.SGD","LU1989771016.USD","LU1291159041.SGD","IE0009355771.USD","LU1267930573.SGD","LU2543165471.USD","LU1548497426.USD","LU0320765489.SGD","LU2125910336.SGD","LU2092937221.SGD","IE00BQXX3C00.GBP","BK4588","IE00BQXX3F31.USD","IE00B2B36J28.USD","LU0070302665.USD","IE00B19Z9505.USD","LU1815333072.USD","LU1623119135.USD","BK4533","LU1803068623.USD","LU2720916845.USD","LU0128525929.USD","IE00BKPKM429.USD","LU2764263039.SGD","LU2211815571.USD","LU1720051017.SGD","BK4585","LU2298321311.HKD","TMO","LU0345770993.USD","LU2764262908.HKD","BK4581","IE0034235188.USD","LU0061474960.USD","LU0114720955.EUR","LU0432979614.USD","LU1023059063.AUD","LU2211814178.USD","LU0528227936.USD","LU2468319806.SGD","LU2357305700.SGD","IE00BJJMRZ35.SGD","LU1720051108.HKD","LU0266013472.USD","LU0208291251.USD","LU1854104046.USD","LU1670627923.USD","LU0251142724.SGD","LU1153585028.USD","LU0234572021.USD","TMED","LU2041044095.USD","LU1633808545.USD","LU2264538146.SGD","BK4548","LU1791710582.SGD","GB00BDT5M118.USD","LU0048573561.USD","LU1923622291.USD","BK4535","LU0096362180.USD","IE00B19Z8X17.USD","LU1061106388.HKD","LU2112291526.USD","LU0823416689.USD","LU2125910179.SGD","IE0002141913.USD","LU0345770308.USD","BK4121","LU0640476718.USD","LU2360108059.USD","LU1280957306.USD","LU2125909916.SGD","LU0742534661.SGD","LU2433249047.HKD","LU0310800379.SGD","LU0342679015.USD","LU1923621640.USD","LU0316494557.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673070168","title":"Illumina Releases SpliceAI2, Says Model Identifies 17% More Disease-Relevant Splice Variants in Rare Disease Dataset","url":"https://stock-news.laohu8.com/highlight/detail?id=2673070168","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673070168?lang=en_us&edition=fundamental","pubTime":"2026-10-08 21:16","pubTimestamp":1791465369,"startTime":"0","endTime":"0","summary":"Illumina releases SpliceAI2, says model identifies 17% more disease-relevant splice variants in rare disease datasetIllumina introduced SpliceAI2, a genomic AI model aimed at improving interpretation ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261008:nNDL4Fgntv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","BK4585","ILMN","GNOM","LU0029874061.USD","LU0128526141.USD","BK4588","GNMX","BK4535","BK4121","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673007091","title":"Illumina Releases Spliceai2 to Help Advance Rare Disease Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2673007091","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673007091?lang=en_us&edition=fundamental","pubTime":"2026-10-08 21:15","pubTimestamp":1791465300,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261008:nTUA68FL0K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0128526141.USD","BK4588","BK4534","BK4585","LU0029874061.USD","GNMX","GNOM","ILMN","BK4121","BK4535","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673771071","title":"All Invest Securities Reaffirms Buy Rating on ABL Texcell Diagnostics as Texcell Integration Boosts Growth Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2673771071","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673771071?lang=en_us&edition=fundamental","pubTime":"2026-10-08 19:36","pubTimestamp":1791459400,"startTime":"0","endTime":"0","summary":"ABL Diagnostics SA ( ($FR:ABLD) ) has issued an update. ABL Texcell Diagnostics, listed on Euronext Paris, develops molecular diagnostics, healthca...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/all-invest-securities-reaffirms-buy-rating-on-abl-texcell-diagnostics-as-texcell-integration-boosts-growth-outlook?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/all-invest-securities-reaffirms-buy-rating-on-abl-texcell-diagnostics-as-texcell-integration-boosts-growth-outlook?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HTEC","BMED","HELX","ABLD","GNMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673907263","title":"Alnylam Pharmaceuticals (ALNY) Is Under Securities Fraud Investigation","url":"https://stock-news.laohu8.com/highlight/detail?id=2673907263","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673907263?lang=en_us&edition=fundamental","pubTime":"2026-10-08 19:30","pubTimestamp":1791459030,"startTime":"0","endTime":"0","summary":"Alnylam Pharmaceuticals (NasdaqGS:ALNY) faces an ongoing securities fraud investigation following a downward revision to its 2026 sales guidance.\nInvestigators are examining whether management disclosures around the updated full year 2026 outlook accurately reflected the business conditions at the time.\nThe probe focuses on potential gaps between prior public commentary on future sales expectations and the revised guidance now presented to investors.\nThe securities fraud investigation tied...","market":"us","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-alny/alnylam-pharmaceuticals/news/alnylam-pharmaceuticals-alny-is-under-securities-fraud-inves","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-alny/alnylam-pharmaceuticals/news/alnylam-pharmaceuticals-alny-is-under-securities-fraud-inves","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0109394709.USD","LU0320765992.SGD","LU0889565916.HKD","BK4585","PBE","BK4588","ALNY","BK4548","LU0114720955.EUR","GNMX","LU0882574055.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673106080","title":"Vertex to Report Q3 2026 Financial Results, Host Conference Call and Webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2673106080","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673106080?lang=en_us&edition=fundamental","pubTime":"2026-10-08 04:00","pubTimestamp":1791403217,"startTime":"0","endTime":"0","summary":"Vertex to report Q3 2026 financial results, host conference call and webcastVertex will report third-quarter 2026 financial results on Nov. 2, 2026.Conference call and webcast set for Nov. 2, 2026 at ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nNDL13mQMk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","LU1778281490.HKD","LU0058720904.USD","BK4585","LU0234570918.USD","IBBQ","IE00B4R5TH58.HKD","VRTX","LU2362541513.USD","LU1674673691.USD","BK4532","LU1093756325.SGD","TBXU","IE00B19Z9Z06.USD","LU0889565916.HKD","LU2237438978.USD","BK4567","IE0009355771.USD","PBE","BBH","LU2324357040.USD","LU0823416689.USD","LU0432979614.USD","SG9999013999.USD","IE00B894F039.SGD","IDNA","LU2456880835.USD","IE0002141913.USD","LU0079474960.USD","BK4588","LU2468319806.SGD","LU1035775433.USD","LU1674673428.USD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","GNMX","SG9999001176.SGD","LU2462157665.USD","IE00B19Z9P08.USD","IE00B19Z3B42.SGD","LU0320765992.SGD","SGXZ57979304.SGD","BIB","LU0256863811.USD","IBB","LU1430594728.SGD","SG9999001176.USD","BK4139","LU2089984988.USD","IE00B19Z3581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673011517","title":"Novartis announces FDA approval of Rhapsido for symptomatic dermographism","url":"https://stock-news.laohu8.com/highlight/detail?id=2673011517","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673011517?lang=en_us&edition=fundamental","pubTime":"2026-10-07 23:50","pubTimestamp":1791388212,"startTime":"0","endTime":"0","summary":"Novartis (NVS) announced that the Food and Drug Administration approved Rhapsido as the first treatment for adults with symptomatic dermographism i...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novartis-announces-fda-approval-of-rhapsido-for-symptomatic-dermographism-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novartis-announces-fda-approval-of-rhapsido-for-symptomatic-dermographism-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IEIH","LU0320765489.SGD","LFSC","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","BBP","BK4578","SYNB","TECB","IE00BFTCPJ56.SGD","PINK","BMED","IBB","BK4585","XLVX","MEDX","PSCH","IE0002141913.USD","LU0070302665.USD","BK4588","IE00B4R5TH58.HKD","IDNA","IE0009355771.USD","NVS","MEDI","GDOC","BK4007","IYH","NVIB","LU0211331839.USD","GNMX","FRTY","MRNX","LABU","TBXU","IE00BJT1NW94.SGD","MRNY","BK4532","RSPH","PPH","LU0208291251.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673118620","title":"Novartis Rhapsido® (remibrutinib) receives FDA approval as first treatment for symptomatic dermographism (SD), expanding its use beyond chronic spontaneous urticaria (CSU)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673118620","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673118620?lang=en_us&edition=fundamental","pubTime":"2026-10-07 23:45","pubTimestamp":1791387900,"startTime":"0","endTime":"0","summary":"In Phase III RemIND trial, twice as many adults taking Rhapsido achieved complete hive resolution by Week 12 vs placebo, with responses seen by Week 21SD is most prevalent type of chronic inducible ur","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/07/3376686/0/en/novartis-rhapsido-remibrutinib-receives-fda-approval-as-first-treatment-for-symptomatic-dermographism-sd-expanding-its-use-beyond-chronic-spontaneous-urticaria-csu.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0106831901.USD","RSPH","LU1244550221.USD","MEDI","BBP","BK4581","IE00B3S45H60.SGD","IAI","LU0267386448.USD","LU0795875169.SGD","SYNB","TBXU","LU1064131342.USD","IYH","LU0390134368.USD","BMED","IE00BZ1G4Q59.USD","KBWB","LU2023251221.USD","IDNA","GNMX","GDOC","LU2264538146.SGD","FRTY","LU2487616109.SGD","MRNY","PSCH","LABU","BK4504","LU0210528500.USD","LU1720051017.SGD","TECB","XLVX","LU0528227936.USD","BK4585","NVIB","LU0912757837.SGD","LU1720051108.HKD","MRNX","IBB","LU1668664300.SGD","LU2357305700.SGD","SD","LFSC","LU2028103732.USD","LU1791710582.SGD","LU1989772840.SGD","LU2089284900.SGD","PINK","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673162670","title":"Guardant Health is Maintained at Overweight by Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2673162670","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673162670?lang=en_us&edition=fundamental","pubTime":"2026-10-07 22:43","pubTimestamp":1791384180,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GH/analyst-ratings","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FFOX","GNOM","BK4588","GH","LU0109394709.USD","LU0320765992.SGD","BK4585","GDOC","PTH","BK4551","GNMX","EKG","BK4196","HELX","LU0889565916.HKD","LFSC","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673094788","title":"Thermo Fisher price target raised to $750 from $650 at Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2673094788","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673094788?lang=en_us&edition=fundamental","pubTime":"2026-10-07 18:15","pubTimestamp":1791368120,"startTime":"0","endTime":"0","summary":"Barclays analyst Luke Sergott raised the firm’s price target on Thermo Fisher (TMO) to $750 from $650 and keeps an Overweight rating on the shares....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/thermo-fisher-price-target-raised-to-750-from-650-at-barclays-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/thermo-fisher-price-target-raised-to-750-from-650-at-barclays-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2089984988.USD","IE00BQXX3D17.EUR","LU1153585028.USD","BK4535","LU2720916845.USD","LU2125909593.SGD","LU2041044095.USD","BK4534","HRTS","LU1670628061.USD","BK4588","LU0048573561.USD","LU0528227936.USD","IE0002141913.USD","LU1803068623.USD","LU2211814178.USD","IE00BQXX3C00.GBP","LU2298321311.HKD","BK4566","IE00BFTCPJ56.SGD","LU1548497426.USD","LU1720051017.SGD","IE0034235188.USD","GNMX","IE00BJJMRZ35.SGD","LU0029864427.USD","LU2112291526.USD","IE00B19Z8X17.USD","BK4585","IE00B19Z8W00.USD","LU1988902786.USD","LU1064131342.USD","BK4533","LU0266013472.USD","LU0345770993.USD","LU2764262908.HKD","TMO","FMED","LU1923622614.USD","IE00B1BXHZ80.USD","LU0011850046.USD","LU0096362180.USD","LU0345770308.USD","TMED","BK4121","LU0128525929.USD","LU0342679015.USD","LU0251131958.USD","LU0070302665.USD","LU1854103824.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673068758","title":"Guardant Health Inc Stock (GH) Moved Down by 8.27% on Oct 6: What Investors Need To Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2673068758","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673068758?lang=en_us&edition=fundamental","pubTime":"2026-10-07 03:15","pubTimestamp":1791314128,"startTime":"0","endTime":"0","summary":"• Guardant Health shares dropped due to profit-taking after a multi-month rally.\n• Ongoing unprofitability and high valuation multiples triggered intense selling pressure.\n• The company reported $982.02M in annual revenue and a net profit of $-416.28M.","market":"nz","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262202416-market-movers-gh-20261006","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","LU0320765992.SGD","BK4585","EKG","FFOX","GDOC","BK4196","LU0109394709.USD","GNOM","GNMX","LU0889565916.HKD","PTH","HELX","BK4588","GH","BK4535","LFSC"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}